IOLCP Launches 'Saksham Niveshak' Campaign to Update Shareholder KYC & Prevent Dividend Transfer to IEPF
This campaign is important for all shareholders to ensure their details are updated and they do not lose access to their dividends and shares, while also ensuring the company's compliance with MCA and SEBI regulations. It affects a broad base of investors.
The campaign is a proactive measure by the company to assist shareholders in updating their details and claiming their dividends, ensuring compliance with regulatory requirements and improving investor relations.
* IOL Chemicals and Pharmaceuticals Limited (IOLCP) has initiated a 100-Day Campaign titled "Saksham Niveshak" from 28th July 2025 to 6th November 2025. * The campaign's primary objective is to engage shareholders in updating their KYC and other relevant details, thereby preventing the transfer of unpaid/unclaimed dividends and shares to the Investor Education and Protection Fund (IEPF). * Key areas of focus include: * Payment of Unclaimed/Unpaid Dividends for financial years FY2019-20 to FY2025-26. * KYC Updation, Bank Mandates, Email Registration, and Nomination. * Shareholders holding shares in physical form are advised to submit Form ISR-1 and other applicable forms as per SEBI Circulars to the Company's Registrar and Share Transfer Agent (RTA), M/s Alankit Assignments Limited. * Shareholders holding shares in dematerialized form should contact their Depository Participants (DPs) to register or update their KYC details. * The company published advertisements regarding this campaign in Financial Express and Punjabi Jagran on 29th August 2025.
What to do with a filing like this
IOL Chemicals and Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by IOL Chemicals and Pharmaceuticals Limited. Read the original for the full detail.